X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-14 | KYMR | Booth Bruce | Dir | S - Sale | $40.25 | -127,543 | 806,697 | -14% | -$5,133,263 | |||||
| M | 2024-03-11 | KYMR | Atlas Venture Fund X, L.P. | 10% | S - Sale | $42.20 | -353,357 | 5,504,905 | -6% | -$14,912,376 | |||||
| M | 2024-03-11 | KYMR | Booth Bruce | Dir | S - Sale | $42.20 | -353,357 | 828,830 | -30% | -$14,912,376 | |||||
| D | 2024-03-04 | KYMR | Gollob Jared | Chief Medical Officer | S - Sale+OE | $41.86 | -3,344 | 95,740 | -3% | -$139,967 | |||||
| D | 2024-03-04 | KYMR | Jacobs Bruce N. | CFO | S - Sale+OE | $41.86 | -3,934 | 142,351 | -3% | -$164,664 | |||||
| DM | 2024-02-20 | KYMR | Albers Jeffrey W. | Dir | S - Sale+OE | $39.05 | -5,000 | 0 | -100% | -$195,258 | |||||
| D | 2024-02-09 | KYMR | Gollob Jared | Chief Medical Officer | S - Sale+OE | $35.50 | -46,137 | 74,709 | -38% | -$1,638,071 | |||||
| D | 2024-01-23 | KYMR | Albers Jeffrey W. | Dir | S - Sale+OE | $30.05 | -10,000 | 0 | -100% | -$300,470 | |||||
2024-01-04 | KYMR | Chiniara Ellen | GC | S - Sale | $22.58 | -3,295 | 34,205 | -9% | -$74,416 | ||||||
| DM | 2023-11-02 | KYMR | Bvf Partners L P/Il | See Remarks and Footnotes | P - Purchase | $12.80 | +414,105 | 294,632 | -347% | +$5,301,325 | |||||
| D | 2023-03-02 | KYMR | Caughey Elaine | Chief Business Officer | S - Sale+OE | $31.00 | -714 | 18,986 | -4% | -$22,132 | |||||
| D | 2023-03-02 | KYMR | Gollob Jared | Chief Medical Officer | S - Sale+OE | $31.00 | -1,298 | 74,709 | -2% | -$40,233 | |||||
| D | 2023-03-02 | KYMR | Jacobs Bruce N. | CFO | S - Sale+OE | $31.00 | -1,370 | 104,568 | -1% | -$42,465 | |||||
| DM | 2023-01-11 | KYMR | Bvf Partners L P/Il | See Remarks and Footnotes | P - Purchase | $30.51 | +41,007 | 2,146,105 | +2% | +$1,251,191 | |||||
| M | 2023-01-11 | KYMR | Booth Bruce | Dir | S - Sale | $30.22 | -126,474 | 890,148 | -12% | -$3,821,739 | |||||
| M | 2023-01-11 | KYMR | Atlas Venture Fund X, L.P. | 10% | S - Sale | $30.22 | -126,474 | 5,858,262 | -2% | -$3,821,739 | |||||
| M | 2022-12-14 | KYMR | Booth Bruce | Dir | S - Sale | $31.36 | -382,244 | 917,811 | -29% | -$11,985,954 | |||||
| M | 2022-12-14 | KYMR | Atlas Venture Fund X, L.P. | 10% | S - Sale | $31.36 | -382,244 | 5,984,736 | -6% | -$11,985,954 | |||||
| M | 2022-11-02 | KYMR | Booth Bruce | Dir | S - Sale | $30.01 | -220,016 | 1,001,417 | -18% | -$6,602,952 | |||||
| M | 2022-11-02 | KYMR | Atlas Venture Fund X, L.P. | 10% | S - Sale | $30.01 | -220,016 | 6,366,980 | -3% | -$6,602,952 | |||||
| M | 2022-10-28 | KYMR | Booth Bruce | Dir | S - Sale | $30.26 | -288,702 | 1,049,540 | -22% | -$8,735,143 | |||||
| M | 2022-10-28 | KYMR | Atlas Venture Fund X, L.P. | 10% | S - Sale | $30.26 | -288,702 | 6,586,996 | -4% | -$8,735,143 | |||||
| D | 2022-08-22 | KYMR | Bvf Partners L P/Il | See Remarks and Footnotes | P - Purchase | $26.00 | +545,525 | 257,754 | -190% | +$14,183,650 | |||||
| DM | 2022-05-26 | KYMR | Bvf Partners L P/Il | See Remarks and Footnotes | P - Purchase | $14.34 | +289,426 | 230,637 | -492% | +$4,150,321 | |||||
| D | 2022-05-20 | KYMR | Bvf Partners L P/Il | See Remarks and Footnotes | P - Purchase | $14.00 | +10,100 | 216,772 | +5% | +$141,394 | |||||
| DM | 2022-05-05 | KYMR | Bvf Partners L P/Il | See Remarks and Footnotes | P - Purchase | $19.46 | +250,000 | 216,735 | -752% | +$4,865,365 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |